RAI Conference Centre, Amsterdam
Attending the EWMA conference this year? Then make sure you pass by our stand- 3D16- to see our exciting innovations in Skin and Wound Care! We can’t wait to show you something new for the treatment of Incontinence-Associated Dermatitis (IAD) and wound management. Can’t make it? Don’t worry, you can sign up below for all the latest 3M news and information shared at EWMA, including IAD treatment, revolutionary new product launches and summarised discussions from the expert panel on pressure ulcers.
May 4th 16:00 – 17:00, room Forum
Preventing and treating skin breakdown due to the devastating influences of incontinence, leading to IAD, remains a clinical challenge. Recent evidence suggests a correlation between IAD and pressure ulcers and IAD is known to be painful for patients. How can 3M support you with something new to help you and your patients? Attend the IAD Symposium to learn more. Key Speakers include Professor Lisette Schoonhoven, Professor Dimitri Beeckman, Dr. Jan Kottner, Mary Brennan RN MBA CWON FAACWS and Debra Thayer Msc.
Expert Panel Discussion
May 5th, 12:45-13:45, room Emerald
With the availability of more evidence to support the beneficial use of dressings in pressure ulcer prevention, there appears to be an increasing uptake by clinicians. How does that impact the clinical best practice of always seeking a holistic approach? What about key risk factors such as nutrition, skin microclimate and incontinence? Attend an interactive session with European experts in the field of pressure ulcer prevention and management, chaired by Professor Dimitri Beeckman. The audience can vote live during the session to engage with the expert panel. Panel members include Ms Jacqui Fletcher, Professor Lisette Schoonhoven and Doctor Jan Kottner.
Complete the form below to register and receive our EWMA news including new product launches and a summary of the expert panel discussion on pressure ulcers.
Our goal is to respond to your request within 24 hours. Some questions, however, may need further investigation to provide you with an appropriate response.
Compression therapy is considered the standard of care for treating lower extremity oedema and venous leg ulceration. Reducing the pain and discomfort of venous leg ulcers—and managing the chronic edema that can lead to their development—doesn’t have to be complicated for you or your patients.
3M advanced the science of compression therapy by creating materials engineered to deliver Intelligent Compression Dynamics to provide comfortable, therapeutic compression for the management of venous leg ulcers.
Medical Adhesive—Related Skin Injury (MARSI) refers to the red irritated skin that often occurs when medical adhesives are removed. It occurs across all care settings and age groups, often due to improper selection, application or removal of medical adhesives. This causes unnecessary pain and compromises skin integrity.
With an impressive history in developing adhesive solutions, we at 3M have a unique understanding of how adhesives interact with skin. We use that knowledge to develop products to address patient needs in today’s care setting—and reduce the risk of MARSI.
Incontinence-Associated Dermatitis (IAD) is a painful, problematic skin injury that results from exposure to urine or faeces. This is a miserable patient experience that also increases the risk of complications.
A global panel of experts concluded that a structured skin care regimen is key to maintaining the skin integrity of patients at risk of IAD.
3M™ Cavilon™ Skin Care Solutions—including our new, innovative 3M™ Cavilon™ Advanced Skin Protectant—are key to a skin care regimen that protects patients, even in cases of moderate to severe IAD.